Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Comment by Pandoraon Mar 28, 2024 10:35pm
68 Views
Post# 35959651

RE:New Press Release - Ventripoint Diagnostics Provides Corporate Update and Announces Conference Call

RE:New Press Release - Ventripoint Diagnostics Provides Corporate Update and Announces Conference CallThe one specific item that most of us on this board, with one exception, are looking for in a news release is the sale of units. i.e. how many have we sold and when. In this news release we have the following:

"11. Closing the sale of a VMS+3.2 system to a top 10 U.S. cardiology centre;"

That is a singular unit and it says we are closing the sale -- ie not in the books yet. That is the only thing I can see that has a sense of incoming revenue to it. One of these days it will be nice if we can be surprised by an announcement that we are starting to actually move on the sale of a good number of units.

That outlook should be good for a"Fudster" label by good old Jo.

 



<< Previous
Bullboard Posts
Next >>